Wuhan General Gr Chn
Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Reno, Nevada.
Market Cap & Net Worth: Wuhan General Gr Chn (WUHN)
Wuhan General Gr Chn (PINK:WUHN) has a market capitalization of $11.03K ($11.03K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #47082 globally and #14605 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Wuhan General Gr Chn's stock price $0.00 by its total outstanding shares 55149662 (55.15 Million).
Wuhan General Gr Chn Market Cap History: 2015 to 2025
Wuhan General Gr Chn's market capitalization history from 2015 to 2025. Data shows change from $1.38 Million to $11.03K (-45.30% CAGR).
Wuhan General Gr Chn Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Wuhan General Gr Chn's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2528.73x
Wuhan General Gr Chn's market cap is 2528.73 times its annual revenue
1.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $24.82 Million | $33.28K | $410.00K | 745.80x | 60.53x |
| 2021 | $35.85 Million | $14.18K | -$1.71 Million | 2528.73x | N/A |
Competitor Companies of WUHN by Market Capitalization
Companies near Wuhan General Gr Chn in the global market cap rankings as of March 19, 2026.
Key companies related to Wuhan General Gr Chn by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Wuhan General Gr Chn Historical Marketcap From 2015 to 2025
Between 2015 and today, Wuhan General Gr Chn's market cap moved from $1.38 Million to $ 11.03K, with a yearly change of -45.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $11.03K | 0.00% |
| 2024 | $11.03K | +100.00% |
| 2023 | $5.51K | -99.67% |
| 2022 | $1.65 Million | -95.38% |
| 2021 | $35.85 Million | +44.44% |
| 2020 | $24.82 Million | +1053.85% |
| 2019 | $2.15 Million | -76.01% |
| 2018 | $8.97 Million | -47.55% |
| 2017 | $17.10 Million | +933.33% |
| 2016 | $1.65 Million | +20.00% |
| 2015 | $1.38 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Wuhan General Gr Chn was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.03K USD |
| MoneyControl | $11.03K USD |
| MarketWatch | $11.03K USD |
| marketcap.company | $11.03K USD |
| Reuters | $11.03K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.